From: "Jeffrey E." <jeevacation®gmail.com>

From: "Jeffrey E." <jeevacation®gmail.com> To: Richard Kahr Subject: Re: capital gains Date: Wed, 13 Dec 2017 00:47:49 +0000 yes take On Tue, Dec 12, 2017 at 1:37 PM, Richard Kahn 2016 capital loss carry forward apple realized gains (march 2017 & dec 2017) other cap gains (includes haze trust art sale gains) capital gains thru nov 2017 K-1 's wrote: (30,712,274) 26,940,828 3,836,328 64,882 a) honeycomb - they made a 475 election so all income (20mm investment x 20% returns = 4mm) should be ordinary EDC b) boothbay - portion relating to capital gain from ytd gain of 5.4mm (as fund is up 12.4% thru Nov 2017) is unknown and concerning on 2016 k-1 the majority (95%+) of the income was ordinary business income (EDC), interest and dividends Top 5 Unrealized Losses in Portfolio 1 Ascena Retail Group (50,500 shares) 973,468 2 Teva Pharmaceuticals Mandatory convert (1mm quantity) 604,500 3 Nationwide Bond (2mm quantity) 506,660 4 Royal Bank of Scotland Bond (5mm quantity) 433,817 5 Allergan Mandatory convert (1mm quantity) /611,035 Total Top 5 Unrealized Losses 2,778,480 should we take losses to offset boothbay capital gains and give ourself a cushion so that we come as close to $0 capital gains for 2017 please advise thank you ** jawbone 11,250,000 - should mort sell to RK/someone else for $1 to recognize the loss?? Richard Kahn HBRK Associates Inc. 575 Lexington Avenue 4th Floor EFTA00928419 New York, NY 10022 please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00928420